Racial differences in liver inflammation and fibrosis related to chronic hepatitis C

Kester Crosse1, Onuora G Umeadi, Frank A Anania

  • 1Department of Medicine, The University of Maryland Baltimore School of Medicine, USA.

Insights

Black Americans with Hepatitis C virus (HCV) infection show milder liver disease progression compared to white Americans. This study found less liver inflammation and fibrosis in Black patients, irrespective of iron levels.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Research

Background:

  • Hepatitis C virus (HCV) infection is more common in Black Americans than White Americans.
  • The natural history of HCV in Black patients remains underexplored.
  • Understanding racial differences in HCV progression is crucial for tailored treatment strategies.

Purpose of the Study:

  • To define the natural course of HCV infection in Black Americans.
  • To compare liver histology and clinical parameters between Black and White HCV patients.
  • To investigate potential factors influencing disease severity across racial groups.

Main Methods:

  • Retrospective comparison of 87 Black and 136 White American patients with chronic HCV.
  • Analysis of initial liver tests, HCV genotype, viral load, and liver biopsy findings.
  • Liver biopsies assessed using the Knodell Histologic Activity Index (HAI).

Main Results:

  • Black HCV patients were older and more likely to have HCV genotype 1.
  • Despite similar transmission modes and duration, Black patients exhibited lower mean HAI scores, indicating less necroinflammation and fibrosis.
  • Lower mean serum alanine transaminase (ALT) and iron levels were observed in Black patients.

Conclusions:

  • Black chronic HCV patients demonstrate less severe liver necroinflammation and fibrosis compared to White patients.
  • These histological differences are not attributable to variations in hepatic iron loading.
  • Findings suggest distinct disease trajectories for HCV in different racial groups.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...